Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v1-EN
Language English English
Date Updated 2017-03-24 2017-03-20
Drug Identification Number 02295822 02295822
Brand name APO-VALACYCLOVIR APO-VALACYCLOVIR
Common or Proper name VALACYCLOVIR VALACYCLOVIR
Company Name APOTEX INC APOTEX INC
Ingredients VALACYCLOVIR VALACYCLOVIR
Strength(s) 500MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 BLS 30 BLS
ATC code J05AB J05AB
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-20 0017-03-20
Estimated end date 2017-03-23 2017-04-05
Actual end date 2017-03-23
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments APO-VALACYCLOVIR HCL FCT 500MG 100 BTL is available APO-VALACYCLOVIR HCL FCT 500MG 100 BTL is available
Health Canada comments